We have prepared this infographic with a summary update for the publishing and eSubmission in Taiwan.
The use of the eCTD format is mandatory for NDA submissions and voluntary for all other submission types for pharmaceutical, biologic and radiopharmaceutical drugs for human use since January 1st, 2020. At Asphalion we can guide you with the transition to eCTD required to be filed for each submission.
Download here:
Share
Services
Memberships & Partnerships
Quality Management System
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
